This inventor holds 2 USPTO granted patents. Top assignees: National Taiwan Normal University, Taiwan Tian Shing Biotech Co., Ltd.. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Kwun-min Chen: Innovator in Deep Sea Water Extracts and Tau-Associated Disease Treatments
Introduction
Kwun-min Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the fields of biotechnology and pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Chen's work focuses on the extraction and application of deep sea water and the treatment of tau-associated diseases.
Latest Patents
Chen's latest patents include a method for utilizing deep sea water extract to inhibit the proliferation of certain strains. This invention provides a deep sea water extract that contains an organic component with specific molecular weights, which can be applied in the prevention and treatment of infections. Another significant patent involves a method for treating tau-associated diseases, including Alzheimer's disease, by administering a pharmaceutical composition that comprises a tetrahydropyranol derivative. This method has shown promise in reducing tau aggregation, which is crucial in the management of such diseases.
Career Highlights
Throughout his career, Kwun-min Chen has worked with esteemed institutions such as National Taiwan Normal University and Taiwan Tian Shing Biotech Co., Ltd. His research and innovations have positioned him as a key figure in the biotechnology sector.
Collaborations
Chen has collaborated with notable colleagues, including Guey-Jen Lee-Chen and Cheng-Huang Lin, contributing to the advancement of research in his field.
Conclusion
Kwun-min Chen's innovative work in deep sea water extracts and tau-associated disease treatments highlights his significant impact on biotechnology. His patents reflect a commitment to addressing critical health challenges through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile